Nephrotoxicity: Clinical Trials

3 trials for Nephrotoxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 31Completed 1

Follow Nephrotoxicity: new trials by email Literature Review of Nephrotoxicity trials Research Report on Nephrotoxicity

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity
Addition of sachets of N-acetyl cysteine 1200 mg twice/day to the maintenance dose of colistin, Addition of Alpha-lipoic acid 600mg twice daily to the maintenance dose of colistin - Nephrotoxicity
Phase 2 / Phase 3CompletedAin Shams University1802024-11-012026-02-17
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
Huaier Granule, VEGFR-TKIs - Nephrotoxicity
Phase 2CompletedFudan University762023-01-032026-02-09
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Pantoprazole, High-dose methotrexate infusion duration - Osteosarcoma, Nephrotoxicity
Phase 2CompletedChildren's Hospital of Philadelphia132013-04-012020-03-16

Narrower conditions

Neoplasms (1)  ·  Osteosarcoma (1)  ·  Ototoxicity (1)  ·  Proteinuria (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Chemically-Induced Disorders (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Ear Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathologic Processes (1)  ·  Radiation Injuries (1)  ·  Sarcoma (1)

Interventions

Methotrexate (1)  ·  Pantoprazole (1)

Sponsors

Ain Shams University (1)  ·  Children's Hospital of Philadelphia (1)  ·  Fudan University (1)

Countries

China (1)  ·  Egypt (1)  ·  United States (1)

Top investigators

Dina H El Adly, MSc (1)  ·  Frank M Balis, MD (1)  ·  Lamia M El Wakeel, PhD (1)  ·  Lu Wang (1)

Results publications

PMID 29445029, PMID 33677616